Date: 2013-04-16 08:07:33Pharmaceutical sciences Compounding Form FDA 483 Office of Criminal Investigations Office of Regulatory Affairs Pharmacy Federal Food Drug and Cosmetic Act Center for Drug Evaluation and Research Food and Drug Administration Health Medicine | | FDA’S OVERSIGHT OF NECC AND AMERIDOSE: A HISTORY OF MISSED OPPORTUNITIES? PRELIMINARY MAJORITY STAFF REPORT COMMITTEE ON ENERGY AND COMMERCE U.S. HOUSE OF REPRESENTATIVESAdd to Reading ListSource URL: energycommerce.house.govDownload Document from Source Website File Size: 577,01 KBShare Document on Facebook
|